期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Study on Quality Standards of Jianjin Zhuanggu Paste
1
作者 Bo LIANG Sitong LIU +7 位作者 Yunshuang CAI Cheng GUO Shengzhuang WEI Guiyan LI Chunhui HUANG Qiuyan HUANG Xiaoqi HUANG Xiaolian LIANG 《Agricultural Biotechnology》 2024年第3期75-80,共6页
[Objectives]Some Chinese medicinal materials of Jianjin Zhuanggu Paste were microscopically identified,and several active ingredients were studied by thin-layer identification,which provides reference for further impr... [Objectives]Some Chinese medicinal materials of Jianjin Zhuanggu Paste were microscopically identified,and several active ingredients were studied by thin-layer identification,which provides reference for further improving the quality standards of hospital preparations.[Methods]The effective components of Jianjin Zhuanggu Paste were qualitatively identified by thin-layer chromatography(TLC).[Results]The microscopic identification of the three Chinese medicinal materials in Jianjin Zhuanggu Paste showed the microscopic characteristics of Radix Codonopsis,Radix Astragali and Radix Notoginseng.TLC identification showed that there were characteristic spots of Radix Codonopsis,Radix Astragali,Radix Rehmanniae Preparata and Radix Notoginseng in Jianjin Zhuanggu Paste.[Conclusions]This study established the quality standard research method of Jianjin Zhuanggu Paste,which further strengthens the safety standards of hospital preparations,and improves the clinical efficacy of drugs,as well as the quality standards of hospital preparations to a certain extent. 展开更多
关键词 Jianjin Zhuanggu Paste Microscopic identification Production technique Thin layer chromatography Quality standard
下载PDF
Clinical treatment of myasthenia gravis with deficiency of spleen and kidney based on combination of disease with syndrome theory 被引量:6
2
作者 Chao Jiang Ping Liu +3 位作者 Yan Liang Shaobo Qiu Wenjing Bao Jingsheng Zhang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2013年第4期444-448,共5页
OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG p... OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG patients with a deficiency of both spleen and kidney were randomly divided into an treatment group (n=30) treated with Jianjining granules and Western Medicine (prednisone or pyridostigmine bromide) and a control group (n= 30) treated with Jianjining granules. The dosage of the three drugs was reduced over the course of treatment. After 3 and 6 months of treatment, the curative effect was evaluated with the muscle weakness severity scale (MWSS). RESULTS: The MWSS score after treatment declined significantly in both groups. The score in the treatment group was much lower than that in thecontrol group (P<0.05). The total effective rate was 63.33% (19/30) in the treatment group and 36.67% (11/30) in the control group after 3 months of treatment, and 80.00% (24/30) and 50.00% (15/30), respectively, after 6 months of treatment. The obvious and total effective rates in the treatment group were much higher than those in the control group (P<0.05). After 6 months of treatment, there were no obvious differences (P>0.05) in the obvious and effective rates between the 2 groups. However, the total effective rate in the treatment group was much higher than that in the control group (P<0.01). CONCLUSION: Using the theory on the combination of disease with syndrome, we found that the curative effect of Jianjining and Western Medicine on MG patients with deficiency of both spleen and kidney is worth further exploration. 展开更多
关键词 Myasthenia gravis Deficiency of spleen and kidney jianjining Combination of disease with syndrome
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部